Alibaba Group Unveils Olympic Games Technology Showcase and Future Vision at Olympic Winter Games PyeongChang 2018
Alibaba Group (NYSE:BABA), the world’s largest retail commerce company, kicked off its first Olympic Games as a TOP partner today with the opening of its showcase – “The Olympic Games on the Cloud” – at the Gangneung Olympic Park. The event was attended by Jack Ma, founder and executive chairman of Alibaba Group, Thomas Bach, President of the International Olympic Committee, as well as distinguished guests and former Olympians including Yao Ming (basketball) and Michelle Kwan (figure skating).
The Alibaba technology showcase is an interactive, future-looking experience that shows fans, athletes, organizing bodies and fellow partners Alibaba’s vision for a future Olympic Games - one that runs completely on the cloud. Visitors will explore different Games-related scenarios that illustrate the potential impact of Alibaba’s cloud services and e-commerce platform services on future Olympic Games.
“Our long-term partnership with the Olympic Games is the ultimate showcase for Alibaba, both in terms of what we stand for as a company and how we can use our technology to reimagine the Olympic Games for the digital era,” said Jack Ma, executive chairman of Alibaba Group. “Like the Olympic Games, Alibaba believes in creating a level playing field, giving everyone the chance to compete on the global stage.”
“The IOC is entering into a new era of digitalization which we are doing in partnership with Alibaba,” said IOC President Thomas Bach. “Alibaba is offering us a unique platform to expand the appeal of the Olympic Games and to keep our fans close. I am impressed by the company’s forward-looking, efficiently-driven work and look forward to ten more years of partnership and even more success.”
The partnership between Alibaba Group and the IOC began in January 2017, when the two signed a historic, long-term strategic partnership to transform the Olympic Games for the digital era. Alibaba will serve as the official “Cloud Services” and “E-Commerce Platform Services” partner, and a founding partner of the Olympic Channel through the LA 2028 Games.
Alibaba Cloud ET Sports Brain
At today’s event, Alibaba Group chief marketing officer, Chris Tung, also unveiled Alibaba Cloud ET Sports Brain, a suite of cloud-based and AI-powered solutions that will drive the digital transformation of the Olympic Games to benefit fans, spectators, athletes, venues and organizers.
Built on Alibaba Cloud’s high-performance infrastructure of world-class data centers, CDNs (content delivery networks) and market-leading security services, Alibaba Cloud ET Sports Brain merges data intelligence and machine learning to re-define engagement between fans, organizers, venues and athletes. Potential applications of Alibaba Cloud ET Sports Brain at the Olympic Games include:
- Enhancing the Games Experience: Cloud-driven big data can transform the way fans engage with the Games, creating a seamless, mobile experience moving between offline and online. Fans and athletes would be able to get around the city, find their way to the best events, be prepared for the weather, and experience the Games in new ways with the latest immersive technology.
- Smart City Planning for Host Cities: When future host cities start planning for Olympic Games venues, Alibaba Cloud can use AI to perform big data geospatial analysis to pick the optimal locations.
- Safety and Security at the Games: Cloud-based biometric identification at sports venues that can improve access control, security and crowd management.
- Improving Training Efficiency for Athletes: Deep machine learning can help model relationships between sleep, nutrition and the intensity of training as well as changes in temperature, wind speed, and other natural conditions to support athlete performance.
- Expanding the Reach and Accessibility of Olympic Games Content: Cloud technology can improve storage, search and customization of content, making it easier for rights-holders to cover the Games and for fans to find and share their favorite moments anytime, anywhere.
“The opportunity for technology to positively influence, shape and reimagine the Olympic Games experience is tremendous and we haven’t even scratched the surface yet,” said Chris Tung, CMO of Alibaba Group. “Over the next ten years, Alibaba Cloud services will serve as the foundation of our efforts to drive the digital transformation of the Games, creating a more efficient and enjoyable experience for all audiences.”
To follow Alibaba Group and its Olympic Games activities, visit: www.alizila.com/2018-winter-olympics/.
To download b-roll from the opening event, visit: www.alizila.com/video_category/b-roll/.
To learn more about Alibaba Cloud’s ET Sports Brain, visit: olympics.alibabacloud.com/.
About Alibaba Group
Alibaba Group's mission is to make it easy to do business anywhere. The company aims to build the future infrastructure of commerce. It envisions that its customers will meet, work and live at Alibaba, and that it will be a company that lasts at least 102 years.
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting21.10.2018 01:30 | Tiedote
Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced detailed results from the Phase 3 FINCH 2 clinical trial of filgotinib, an investigational, selective JAK1 inhibitor, in adults with moderately-to-severely active rheumatoid arthritis and prior inadequate response or intolerance to biologic agents. The data, which are being presented as a late-breaking poster at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting in Chicago, suggest filgotinib has a potential role in addressing important unmet needs in the treatment of rheumatoid arthritis. Positive efficacy data from FINCH 2 were previously announced in September 2018. The data show statistically significant improvements in the proportion of patients achieving a range of clinical efficacy endpoints, including the proportion of patients achieving American College of Rheumatology 20 percent (ACR20, primary endpoint), 50 percent
Manchester United and True Religion Launch Denim Range19.10.2018 20:37 | Tiedote
Manchester United (NYSE:MANU) and luxury denim brand True Religion have collaborated to launch a range of premium club branded denim wear. A first for the club, the new global partnership with the iconic American denim brand will see a range of men’s & women’s co-branded styles go on sale beginning 26th October in the club’s Megastore as well as online via United Direct and truereligion.com & eu.truereligion.com. The exclusive collection features jeans, shirts and jackets, including a highly desirable limited edition denim jacket embroidered with the club’s crest. Fans will have the opportunity to win a selection of clothing from the new range by visiting www.manutd.com/truereligion. Manchester United’s Group Managing Director, Richard Arnold, comments: “True Religion is a well-known, established name in fashion, creating unique designs without compromising on quality. The range we have collaborated on includes the same attention to detail and craftsmanship that has made True Religion
Arch Insurance Announces Strategic Leadership Changes19.10.2018 16:10 | Tiedote
Arch Insurance today announced that Matt Shulman will assume the newly created role of CEO, Arch Insurance North America, effective January 1, 2019. In this role, he will lead Arch Insurance’s operations in the United States and Canada. He will report to Nicolas Papadopoulo, Chairman and CEO of Arch Worldwide Insurance Group. Mr. Shulman, who has more than 20 years of experience in the insurance industry, has been with Arch Insurance since 2009 and has served as the President and CEO of Arch Insurance Europe since 2016. “Matt brings significant U.S. and international experience to this role. Under his leadership, together with our senior team, Arch Insurance will continue to enhance our value proposition to our customers through a robust, diversified product portfolio, creative solutions and excellent service,” Mr. Papadopoulo said. Arch Insurance has also created a new organizational structure with three Chief Underwriting Officers (CUO) dedicated to specific lines of business. These
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer19.10.2018 15:00 | Tiedote
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients. Data for these secondary endpoints will be presented in a poster discussion at the European Society for Medical Oncology (ESMO) 2018 Congress on Friday, October 19 at 2:00 p.m. CET in Munich, Germany. These results further support ALUNBRIG as a potential treatment for adults with ALK+ locally advanced or metastatic NSCLC who had not received a prior ALK inhibitor. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSCLC. “ALK+ NSCLC often spreads to the brain, so having options that can clearly demonstrate efficacy both in the brain an
Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene19.10.2018 14:54 | Tiedote
Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO® (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF in patients aged 12 to <24 months, who have specific mutations in the CFTR gene. “Cystic fibrosis is a chronic, progressive disease that is present at birth, with symptoms often occurring in infancy, so early treatment is crucial to deliver the best possible outcomes for patients,” said Reshma Kewalr
Tradeshift Announces Q3 2018 Results19.10.2018 14:00 | Tiedote
Tradeshift, the leader in supply chain payments and marketplaces, today announced results from the third quarter of 2018, marking the tenth quarter in a row of successive growth and beating targets. Tradeshift’s third quarter growth stats announced today include: YoY revenue grew 400 percent (trailing 12 months) YoY new bookings grew 284 percent YoY gross merchandise volume (GMV) grew 262 percent New total contract value grew by $47M in Q3 Tradeshift’s customer roster continued strong growth this quarter adding 27 new customers, including Hertz, Shiseido, ECU, and Fortune 500 leaders in retail apparel, agriculture, engineering and construction, hospitality, travel and food delivery. Tradeshift also expanded its app ecosystem by adding a key partnership with Coface, a global credit insurer. Coface has announced a new app solution on the Tradeshift platform offering risk and business information services to help businesses make decisions by ensuring greater financial transparency between
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme